Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11947003 | 0.96 | ALDH1A1 (0.41) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL16543285 | 0.87 | KDM4E (0.45) | KDM4ETDP1L3MBTL1ALDH1A1MAPT | |
| SCHEMBL14211983 | 0.87 | KDM4E (0.45) | KDM4ETDP1L3MBTL1ALDH1A1MAPT | |
| SCHEMBL11947021 | 0.86 | ADORA2A (0.39) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL19932430 | 0.85 | GAA (0.41) | KDM4EALDH1A1CYP1A2MAPTCYP2C19 | |
| SCHEMBL14447265 | 0.85 | ALDH1A1 (0.46) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL17879133 | 0.85 | TDP1 (0.46) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL14447271 | 0.85 | ALDH1A1 (0.46) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL13492528 | 0.85 | ALDH1A1 (0.37) | ADKKDM4ETDP1L3MBTL1ALDH1A1 | |
| SCHEMBL14447304 | 0.83 | ALDH1A1 (0.48) | ADKKDM4ETDP1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8623523-B2 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-8623523-B2 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20120211738-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-23 | — | — | US | disclosed |
| US-20120211738-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-23 | — | — | US | disclosed |
| US-8173277-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8173277-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20110186825-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-08-04 | — | — | US | disclosed |
| US-20110186825-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-08-04 | — | — | US | disclosed |
| US-7901792-B2 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7901792-B2 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-08 | — | — | US | disclosed |
| WO-2007032258-A1 | QUINOXALINE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE USING THE SAME | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-22 | — | — | WO | disclosed |
| US-20070059553-A1 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-03-15 | — | — | US | disclosed |
| US-20070059553-A1 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070059553-A1 | Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same | CRY1, CRY2, ARL1 | ADK 2480/4885KDM4E 347/4885TDP1 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.